• Arai K. and Lo E. H. (2009) Experimental models for analysis of oligodendrocyte pathophysiology in stroke. Exp. Transl. Stroke Med. 1, 6.
  • Chen G., Ray R., Dubik D., Shi L., Cizeau J., Bleackley R. C., Saxena S., Gietz R. D. and Greenberg A. H. (1997) The E1B 19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis. J. Exp. Med. 186, 19751983.
  • Dawson M. R., Polito A., Levine J. M. and Reynolds R. (2003) NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol. Cell. Neurosci. 24, 476488.
  • Deng W., Rosenberg P. A., Volpe J. J. and Jensen F. E. (2003) Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors. Proc. Natl Acad. Sci. USA 100, 68016806.
  • Deng W., Wang H., Rosenberg P. A., Volpe J. J. and Jensen F. E. (2004) Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc. Natl Acad. Sci. USA 101, 77517756.
  • Giatromanolaki A., Koukourakis M. I., Sowter H. M., Sivridis E., Gibson S., Gatter K. C. and Harris A. L. (2004) BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer. Clin. Cancer Res. 10, 55665571.
  • Horner P. J., Power A. E., Kempermann G., Kuhn H. G., Palmer T. D., Winkler J., Thal L. J. and Gage F. H. (2000) Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J. Neurosci. 20, 22182228.
  • Ishida M., Sunamura M., Furukawa T., Akada M., Fujimura H., Shibuya E., Egawa S., Unno M. and Horii A. (2007) Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis. World J. Gastroenterol. 13, 45934597.
  • Khayyam N., Thavendiranathan P., Carmichael F. J., Kus B., Jay V. and Burnham W. M. (1999) Neuroprotective effects of acetylsalicylic acid in an animal model of focal brain ischemia. NeuroReport 10, 371374.
  • Lakhan S. E., Kirchgessner A. and Hofer M. (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 7, 97.
  • Li Y., Wang Y., Kim E., Beemiller P., Wang C. Y., Swanson J., You M. and Guan K. L. (2007) Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb. J. Biol. Chem. 282, 3580335813.
  • Li A., Lv S., Yu Z., Zhang Y., Ma H., Zhao H., Piao H., Li S., Zhang N. and Sun C. (2010) Simvastatin attenuates hypomyelination induced by hypoxia-ischemia in neonatal rats. Neurol. Res. 32, 945952.
  • Martin L. J., Al-Abdulla N. A., Brambrink A. M., Kirsch J. R., Sieber F. E. and Portera-Cailliau C. (1998) Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 46, 281309.
  • McTigue D. M., Tripathi R. and Wei P. (2006) NG2 colocalizes with axons and is expressed by a mixed cell population in spinal cord lesions. J. Neuropathol. Exp. Neurol. 65, 406420.
  • Nakamura Y., Kitamura N., Shinogi D., Yoshida M., Goda O., Murai R., Kamino H. and Arakawa H. (2012) BNIP3 and NIX mediate Mieap-induced accumulation of lysosomal proteins within mitochondria. PLoS ONE 7, e30767.
  • Niu J., Mei F., Li N., Wang H., Li X., Kong J. and Xiao L. (2010) Haloperidol promotes proliferation but inhibits differentiation in rat oligodendrocyte progenitor cell cultures. Biochem. Cell Biol. 88, 611620.
  • Niu J., Mei F., Wang L., Liu S., Tian Y., Mo W., Li H., Lu Q. R. and Xiao L. (2012) Phosphorylated olig1 localizes to the cytosol of oligodendrocytes and promotes membrane expansion and maturation. Glia 60, 14271436.
  • Pandya J. D., Sullivan P. G. and Pettigrew L. C. (2011) Focal cerebral ischemia and mitochondrial dysfunction in the TNFalpha-transgenic rat. Brain Res. 1384, 151160.
  • Tyler W. A., Gangoli N., Gokina P., Kim H. A., Covey M., Levison S. W. and Wood T. L. (2009) Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation. J. Neurosci. 29, 63676378.
  • Vande Velde C., Cizeau J., Dubik D., Alimonti J., Brown T., Israels S., Hakem R. and Greenberg A. H. (2000) BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol. Cell. Biol. 20:54545468.
  • Volpe J. J., Kinney H. C., Jensen F. E. and Rosenberg P. A. (2011) The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int. J. Dev. Neurosci. 29, 423440.
  • Walls K. C., Ghosh A. P., Ballestas M. E., Klocke B. J. and Roth K. A. (2009) bcl-2/Adenovirus E1B 19-kd interacting protein 3 (BNIP3) regulates hypoxia-induced neural precursor cell death. J. Neuropathol. Exp. Neurol. 68, 13261338.
  • Yu Z., Li S., Lv S. H., Piao H., Zhang Y. H., Zhang Y. M., Ma H., Zhang J., Sun C. K. and Li A. P. (2009) Hypoxia-ischemia brain damage disrupts brain cholesterol homeostasis in neonatal rats. Neuropediatrics 40, 179185.
  • Yurkova N., Shaw J., Blackie K., Weidman D., Jayas R., Flynn B. and Kirshenbaum L. A. (2008) The cell cycle factor E2F-1 activates Bnip3 and the intrinsic death pathway in ventricular myocytes. Circ. Res. 102, 472479.
  • Zaidi A. U., Bessert D. A., Ong J. E., Xu H., Barks J. D., Silverstein F. S. and Skoff R. P. (2004) New oligodendrocytes are generated after neonatal hypoxic-ischemic brain injury in rodents. Glia 46, 380390.
  • Zhang Z., Yang X., Zhang S., Ma X. and Kong J. (2007) BNIP3 upregulation and EndoG translocation in delayed neuronal death in stroke and in hypoxia. Stroke 38, 16061613.